Metabolic  	Metabolic  	 NNP	O
and  	and  	 CC	O
organ  	organ  	 JJ	B-NP
protective  	protective  	 JJ	I-NP
properties  	properties  	 NNS	I-NP
of  	of  	 IN	O
various  	various  	 JJ	O
infusion  	infusion  	 NN	B-NP
solutions  	solutions  	 NNS	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
choice  	choice  	 NN	O
of  	of  	 IN	O
starting  	starting  	 VBG	B-NP
therapy  	therapy  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
pre-admission  	pre-admission  	 JJ	B-NP
stage  	stage  	 NN	I-NP
of  	of  	 IN	I-NP
acetic  	acetic  	 JJ	I-NP
acid  	acid  	 NN	I-NP
poisoning  	poisoning  	 VBD	O
We  	We  	 PRP	O
conducted  	conducted  	 VBD	O
an  	an  	 DT	O
open  	open  	 JJ	O
prospective  	prospective  	 JJ	B-NP
study  	study  	 NN	I-NP
in  	in  	 IN	O
60  	60  	 CD	O
patients  	patients  	 NNS	O
( 	( 	 -LRB-	O
30  	30  	 CD	O
men  	men  	 NNS	O
and  	and  	 CC	O
30  	30  	 CD	O
women 	women 	 NNS	O
)  	)  	 -RRB-	O
with  	with  	 IN	O
acetic  	acetic  	 JJ	B-NP
acid  	acid  	 NN	I-NP
poisoning 	poisoning 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
randomization  	randomization  	 NN	B-NP
was  	was  	 VBD	O
performed  	performed  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
groups 	groups 	 NNS	O
,  	,  	 ,	O
taking  	taking  	 VBG	O
into  	into  	 IN	O
account  	account  	 NN	O
the  	the  	 DT	O
tactics  	tactics  	 NNS	O
of  	of  	 IN	O
infusion  	infusion  	 JJ	B-NP
therapy 	therapy 	 NN	I-NP
:  	:  	 :	O
group  	group  	 NN	B-NP
I--15  	I--15  	 CD	I-NP
patients  	patients  	 NNS	I-NP
who  	who  	 WP	O
did  	did  	 VBD	O
not  	not  	 RB	O
receive  	receive  	 VB	O
an  	an  	 DT	O
infusion  	infusion  	 NN	B-NP
therapy  	therapy  	 NN	I-NP
at  	at  	 IN	O
a  	a  	 DT	O
pre-admission  	pre-admission  	 JJ	B-NP
stage 	stage 	 NN	I-NP
;  	;  	 :	O
group  	group  	 NN	B-NP
II--15  	II--15  	 CD	I-NP
patients  	patients  	 NNS	I-NP
who  	who  	 WP	O
received  	received  	 VBD	O
the  	the  	 DT	O
infiusion  	infiusion  	 JJ	B-NP
therapy  	therapy  	 NN	I-NP
with  	with  	 IN	O
solution  	solution  	 NN	B-NP
of  	of  	 IN	I-NP
sodium  	sodium  	 JJ	I-NP
chloride  	chloride  	 NN	I-NP
0.9 	0.9 	 CD	O
% 	% 	 NN	O
;  	;  	 :	O
group  	group  	 NN	B-NP
III--15  	III--15  	 CD	I-NP
patients  	patients  	 NNS	I-NP
who  	who  	 WP	O
received  	received  	 VBD	O
the  	the  	 DT	O
infusion  	infusion  	 NN	B-NP
therapy  	therapy  	 NN	I-NP
with  	with  	 IN	O
modified  	modified  	 JJ	O
gelatin  	gelatin  	 NNS	B-NP
( 	( 	 -LRB-	O
Gelofusinwn 	Gelofusinwn 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
group  	group  	 NN	B-NP
IV-15  	IV-15  	 CD	I-NP
patients  	patients  	 NNS	I-NP
who  	who  	 WP	O
received  	received  	 VBD	O
the  	the  	 DT	O
infusion  	infusion  	 NN	B-NP
therapy  	therapy  	 NN	I-NP
with  	with  	 IN	O
reamberinum 	reamberinum 	 NN	B-NP
.  	.  	 .	O
We  	We  	 PRP	O
found  	found  	 VBD	O
that  	that  	 IN	O
the  	the  	 DT	O
most  	most  	 RBS	O
favorable  	favorable  	 JJ	O
results  	results  	 NNS	O
were  	were  	 VBD	O
noted  	noted  	 VBN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
of  	of  	 IN	O
group  	group  	 NN	O
IV  	IV  	 NNP	O
in  	in  	 IN	O
the  	the  	 DT	O
early  	early  	 JJ	O
posttraumatic  	posttraumatic  	 JJ	B-NP
period 	period 	 NN	I-NP
.  	.  	 .	O
